Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib

Study investigated the effect of single hit TP53 mutation versus multi-hit TP53 mutations in patients with chronic lymphocytic leukemia treated with ibrutinib.